Article By:
NASDAQ GlobeNewswire
Monday, July 6, 2020 2:12 PM EDT
Pacira BioSciences, Inc., today announced that it intends to offer, subject to market and other conditions, $300.0 million aggregate principal amount of convertible senior notes due 2025.
In this article: PCRX